Synchron

About

Synchron is a bioelectronics medicine company that develops neuromodulation solutions for previously-untreatable nervous system conditions.

Brooklyn,New York,United States
11 - 50
https://synchron.com

Highlights

Details

Last Funding Type: Series C
Last Funding Money Raised: $75M
Industries: Computer,Information Technology,Manufacturing,Marketing,Medical,Medical Device
Founded date: Apr 1, 2016
Number Of Employee: 11 - 50
Operating Status: Active
Legal Name: Synchron, Inc.

Synchron manufactures and markets a medical device that can be delivered to the brain with a catheter to record neuron signals that might be used to control an advanced prosthetic.

Funding Rounds

Number of Funding Rounds

Total Funding Amount

5

$200M

Synchron has raised a total of $200M in funding over 2 rounds. Their latest funding was raised on Dec 16, 2022 from a Series C round.

Announced Date	Round	Money Raised	Number of Investors	Lead Investors	Post Valuation
Dec 16, 2022	Series C	$75M	1	ARCH Venture Partners	—	Detail
Dec 15, 2022	Series C	$75M	17	ARCH Venture Partners	—	Detail
Feb 4, 2022	Funding Round	—	1	Max Hodak	—	Detail
Jun 3, 2021	Series B	$40M	12	Khosla Ventures	—	Detail
Apr 4, 2017	Series A	$10M	2	Neurotechnology Investors	—	Detail

Investors

Number of Lead Investors

Number of Investors

5

22

Synchron is funded by 22 investors. ARCH Venture Partners and Max Hodak are the most recent investors.

Investor Name	Lead Investor	Funding Round
ARCH Venture Partners	Yes	Series C
Max Hodak	Yes	Funding Round
Alumni Ventures	—	Series C
Bezos Expeditions	—	Series C
Forepont Capital Partners	—	Series C
Gates Frontier fund	—	Series C
General Advance	—	Series C
Greenoaks	—	Series C
ID8 Investments	—	Series C
Khosla Ventures	—	Series C